Pharmerit International, Bethesda, MD, USA.
The Psychometrics Team, Sheridan, WY, USA.
Qual Life Res. 2024 Apr;33(4):1075-1084. doi: 10.1007/s11136-023-03587-8. Epub 2024 Jan 24.
Patient-reported outcome (PRO) questionnaires considered in this paper contain multiple subscales, although not all subscales are equally relevant for administration in all target patient populations. A group of measurement experts, developers, license holders, and other scientific-, regulatory-, payer-, and patient-focused stakeholders participated in a panel to discuss the benefits and challenges of a modular approach, defined here as administering a subset of subscales out of a multi-scaled PRO measure. This paper supports the position that it is acceptable, and sometimes preferable, to take a modular approach when administering PRO questionnaires, provided that certain conditions have been met and a rigorous selection process performed. Based on the experiences and perspectives of all stakeholders, using a modular approach can reduce patient burden and increase the relevancy of the items administered, and thereby improve measurement precision and eliminate wasted data without sacrificing the scientific validity and utility of the instrument. The panelists agreed that implementing a modular approach is not expected to have a meaningful impact on item responses, subscale scores, variability, reliability, validity, and effect size estimates; however, collecting additional evidence for the impact of context may be desirable. It is also important to recognize that adequate rationale and evidence (e.g., of fit-for-purpose status and relevance to patients) and a robust consensus process that includes patient perspectives are required to inform selection of subscales, as in any other measurement circumstance, is expected. We believe that the considerations discussed within (content validity, administration context, and psychometric factors) are relevant across multiple therapeutic areas.
本文考虑的患者报告结局(PRO)问卷包含多个子量表,尽管并非所有子量表在所有目标患者人群中进行管理时都同等相关。一组测量专家、开发者、许可证持有者以及其他关注科学、监管、支付方和患者的利益相关者参加了一个小组讨论,讨论了模块化方法的优势和挑战,这里将模块化方法定义为从多尺度 PRO 测量中管理子量表的子集。本文支持这样一种观点,即当管理 PRO 问卷时,采取模块化方法是可以接受的,有时甚至是更好的做法,前提是满足了某些条件并执行了严格的选择过程。基于所有利益相关者的经验和观点,使用模块化方法可以减轻患者负担,提高所管理项目的相关性,从而提高测量精度并消除浪费数据,同时不牺牲仪器的科学有效性和实用性。小组成员一致认为,预计实施模块化方法不会对项目反应、子量表评分、变异性、可靠性、有效性和效应大小估计产生有意义的影响;然而,可能需要收集更多有关背景影响的证据。同样重要的是要认识到,与任何其他测量情况一样,需要有足够的理由和证据(例如,适合用途的状态和与患者的相关性)以及包括患者观点的强大共识过程来告知子量表的选择。我们认为,本文讨论的考虑因素(内容有效性、管理背景和心理计量学因素)与多个治疗领域都相关。